Document:

Exhibit 10.1

 Exhibit 10.1 
  

			
	

	  	GRANTED
	  	THE COURT OF CHANCERY OF THE STATE OF DELAWARE
		
		  	IN AND FOR NEW CASTLE COUNTY

  

					
	GAZIT-GLOBE LTD., an Israeli real	  	)	  	
	 estate investment company,
	  	)	  	
		  	)	  	
	 Plaintiff,
	  	)	  	
		  	)	  	
	 v.
	  	)	  	C.A. No. 2530-N
		  	)	  	
	 THE MILLS CORPORATION, a
	  	)	  	
	 Delaware corporation,
	  	)	  	
		  	)	  	
	 Defendant.
	  	)	  	

 STIPULATED FINAL ORDER 
 Subject to the approval of the Court, Gazit-Globe Ltd. (“Gazit”) and The Mills Corporation (“Mills” or the “Company”), by
their attorneys, hereby stipulate and agree to the following Order and Final Judgment: 
 1. Mills shall hold its annual meeting of
stockholders for 2006 (the “2006 Annual Meeting”) on December 29, 2006. The 2006 Annual Meeting shall not be postponed, adjourned, or otherwise rescheduled. 
 2. The record date for the 2006 Annual Meeting shall be December 1, 2006. 
 3. The shares of stock represented at the 2006 Annual Meeting, either in person or by proxy, and entitled to vote thereat, shall constitute a quorum for
the purpose of the 2006 Annual Meeting, notwithstanding any provision in the Mills certificate of incorporation or bylaws to the contrary. 
 4. At the 2006 Annual Meeting, the following nominees (the “Agreed Nominees”) shall stand for election to the director class that will next stand for election in 2009: Jon N. Hagan, Keith M. Locker, Mark S. Ordan, and S. Joseph
Bruno. 
  

 1 

 5. No nominees other than the Agreed Nominees shall stand for election at the 2006 Annual Meeting.

 6. No business shall be conducted at the 2006 Annual Meeting other than (i) the election of directors and (ii) ratification of
the selection of Mills’ independent auditor. 
 7. The number of directors comprising the entire Board of Directors of Mills shall not
exceed 14 until after the annual meeting of stockholders for 2007 (the “2007 Annual Meeting”). 
 8. Within one business day of the
filing of this stipulated final order with the Court, the parties shall issue jointly the press release attached as Exhibit A. The parties shall not otherwise comment on this litigation. 
 9. Each party shall bear its own costs related to this litigation. 
 10. Except as specifically provided herein, the action is dismissed with prejudice. 
  

					
	/s/ J. Travis Laster	 		 	/s/ Lawrence C. Ashby
	J. Travis Laster (#3514)	 		 	Lawrence C. Ashby (#468)
	Matthew F. Davis (#4696)	 		 	Carolyn S. Hake (#3839)
	Abrams & Laster LLP	 		 	Ashby & Geddes
	Brandywine Plaza West	 		 	222 Delaware Avenue
	1521 Concord Pike, Suite 303	 		 	P.O. Box 1150
	Wilmington, Delaware 19803	 		 	Wilmington, Delaware 19899
	 (302) 778-1000
	 		 	(302) 654-1888
			
	 Attorneys for Plaintiff
	 		 	Attorneys for Defendant

  

 2 

	
	SO ORDERED this          day of
                    , 2006
	
	   
	The Honorable William B. Chandler, III

  

 3 

 Court: DE Court of Chancery 
 Judge: Chandler, William B 
 File & Serve reviewed Transaction ID: 13093419 
 Current date: 12/5/2006 
 Case number: 2530-N 
 Case name: Gazit Globe Ltd vs Mills Corp 
  

	
	/s/ Judge William B Chandler IIIEX10.2

 Exhibit 10.2 
 December 5, 2006 
 Gazit-Globe Ltd. 
 1660 NE
Miami Gardens Drive 
 Suite 1 
 North Miami Beach, FL 33179

 Attention: Chaim Katzman 
 Ladies and Gentlemen: 

In connection with our discussions of possible transactions involving The Mills Corporation and/or its subsidiaries, affiliates or divisions (the
“Company”), Gazit-Globe Ltd (together with its affiliates, “you”) has requested information concerning the Company. As a condition to such information being furnished to you and your Representatives (as defined below), you agree
that you and your Representatives will treat any information (whether (i) prepared or otherwise provided to you by the Company or its Representatives (as defined below) or gathered by inspection, (ii) in written, oral, electronic or other
form, (iii) identified as “confidential” or otherwise, or (iv) prepared before, on or after the date hereof) concerning any aspect of the Company which is furnished to you or any of your Representatives by or on behalf of the
Company (herein collectively referred to as the “Confidential Information”) in accordance with the provisions of this letter agreement and to take or abstain from taking certain other actions herein set forth. 
 The Company agrees that it will provide you a general description of the nature of the Confidential Information that it intends to deliver to you pursuant to this letter
agreement prior to delivering such Confidential Information, and will not deliver any Confidential Information that you specifically ask not to receive (and the Company will use reasonable efforts to provide you with sufficient opportunity to object
prior to delivering any such Confidential Information). However, any Confidential Information delivered to you by the Company shall be subject to the provisions of this letter agreement without regard to the Company’s compliance with the
preceding sentence. 
 The term “Confidential Information” shall be deemed to include notes, analyses, compilations, summaries, data, studies,
interpretations, forecasts, records, memoranda or other documents or information prepared by you or your Representatives which contain or are based on any Confidential Information. The term “Confidential Information” does not include
information which (i) is already in your or your Representatives’ possession, provided that such information is not subject to another confidentiality agreement or obligation of secrecy between you or your Representatives and the Company,
and is not known by you or your Representatives to be subject to any other confidentiality agreement or obligation of secrecy with the Company, (ii) is or becomes generally available to the public other than as a result of a disclosure,
directly or indirectly, by you or your Representatives in violation of this letter agreement, (iii) is or becomes available to you or your Representatives from a source other than the Company or its 

 
Representatives, provided that such source is not known by you to be bound by a confidentiality agreement with or other obligation of secrecy to the Company
with respect to such information or (iv) is independently developed by you or your Representatives without use of any Confidential Information. 
 “Representatives” of any person shall mean its affiliates and the members, managers, partners, directors, officers, employees, controlling persons, representatives, agents and advisors of such person and its affiliates. An
“affiliate” of any person shall mean any other person that directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, the first person. For purposes of this definition,
“control” of a person means the possession of power to direct or cause the direction of management and policies of such person, whether through ownership of voting securities, by contract or otherwise and shall be deemed to exist by virtue
of the ownership or control of more than ten percent (10%) of the capital or voting rights of such person. 
 Confidentiality - You hereby
agree that the Confidential Information will be kept confidential by you and your Representatives and will not be disclosed by you or any of your Representatives except as expressly permitted by this letter agreement, and that any of such
information may be disclosed to your Representatives only on a “need to know basis” and only if you have informed such Representatives of the obligations contained herein and they have agreed, or otherwise have a duty, to keep the
Confidential Information confidential. You agree to be responsible for any breach of this letter agreement by yourself or by any of your Representatives (it being understood that such responsibility shall be in addition to and not by way of
limitation of any right or remedy the Company may have against your Representatives with respect to such breach). 
 Non-Disclosure - In
addition, except as required by law as set forth below, without the prior written consent of the Company, you will not, and will direct your Representatives not to, disclose to any person that you or any of your Representatives has received
Confidential Information or that Confidential Information has been made available to you or them. The matters contemplated by the foregoing sentence shall be subject to the same exceptions to non-disclosure as if they were “Confidential
Information” for purposes of this letter agreement. You acknowledge that disclosure of any of the information described in the preceding sentence may irreparably damage the Company or its affiliates. The term “person” as used in this
letter agreement will be interpreted broadly to include the media (electronic, print or otherwise), publicly available Internet pages, any governmental representative or authority or any corporation, company, limited liability company, enterprise,
association, partnership, group or other entity or individual. 
 Notwithstanding anything herein to the contrary, the Company acknowledges that (i) you
have previously filed a Schedule 13D, as amended, with the Securities and Exchange Commission, and (ii) this letter agreement does not prohibit you from continuing to file amendments to your Schedule 13D as required by law or making other
legally required filings in the future; provided, however, that such amendments and filings shall not be used to evade your obligations set forth in the next paragraph. 

 Standstill - Subject to the immediately following paragraph, as a condition to any further discussions
between you and us with respect to a possible transaction, and to the provision of any additional Confidential Information to you, you agree that, until the earlier of March 30, 2007 and (y) the date on which the Company enters into, or
publicly recommends, a Competing Transaction (as defined below), neither you nor any of your affiliates shall, without the prior written request of the Company, alone or jointly or in concert with any other person (including by providing financing
to any other person), effect or seek, offer or propose (whether publicly or otherwise) to effect (a) the acquisition of record or beneficial ownership of any securities or rights to acquire any securities of the Company or any of its
subsidiaries, or of any rights or options to acquire such ownership (including from a person other than the Company); (b) the acquisition of any assets owned or managed by or interest in assets owned or managed by the Company or any of its
subsidiaries (including any rights or options to acquire any such assets) (including from a person other than the Company); (c) the commencement of any tender or exchange offer for any securities of the Company or any of its subsidiaries;
provided that you shall have the right to tender your shares into any tender or exchange offer not commenced by you; (d) the participation in any “solicitation” of “proxies” (as such terms are used in the proxy rules of the
Securities and Exchange Commission) or consents to vote or otherwise with respect to any voting securities of the Company or any of its subsidiaries; (e) except as required by applicable law, the making of any public announcement with respect
to any proposal for or offer of any extraordinary transaction involving the Company or any of its securities or assets (or those of its subsidiaries); (f) any other action, to seek to control the management, Board of Directors or policies of
the Company or any of its subsidiaries; (g) the formation, joining or in any way participating in a “group” (as defined under the Securities Exchange Act of 1934) with respect to the Company; (h) to materially assist or act as a
financing source for, or otherwise invest in, any other person to assist them in undertaking any of the foregoing; or (i) any action that could require the Company to make a public announcement as to any of the foregoing; provided,
however, that the Company is conducting a strategic alternatives process and you shall be invited to participate in such strategic alternatives process and you shall be afforded an opportunity comparable to that of any other party to submit a
proposal relating to an extraordinary transaction with the Company. You further agree during such period not to (i) request, directly or indirectly, that the Company (1) amend or waive any provision of this paragraph (including this
sentence), or (2) otherwise consent to any action inconsistent with any provision of this paragraph (including this sentence); (ii) take any initiative with respect to the Company or any of its affiliates or securities that would
reasonably be expected to require the Company or any such affiliate to make a public announcement regarding (1) such initiative, (2) any of the activities referred to in this paragraph, or (3) the possibility of a transaction
involving you or your affiliates, in each case, subject to the immediately following paragraph. 
 Notwithstanding the foregoing, if you shall have at any
time provided written notice to the Company that you no longer wish to participate in its strategic alternatives process, nothing herein shall prevent you from participating or agreeing to participate as a financing source for a potential
transaction relating to the Company or its assets by a third party; provided that such third party has signed a confidentiality agreement with the Company and is in compliance with any standstill or confidentiality obligations to the Company;
provided further, that upon notice from you, the Company consents in writing (such consent not to be unreasonably withheld or delayed) to such participation. For purposes of this paragraph, a “Competing Transaction” means (i) the sale
or disposition of all or substantially all of the assets of the Company, or of 

 
assets of the Company with a fair market value in the aggregate of at least $1,500,000,000, (ii) a transaction with a third party constituting a change
of control of the Company (whether by merger, consolidation, tender offer, share or other equity exchange, similar business combination or otherwise), or (iii) the issuance by the Company or its subsidiaries of equity securities of the Company
or its subsidiaries (or of rights to acquire such securities or securities convertible or exchangeable into any such securities) for aggregate consideration of at least $500,000,000. Nothing herein shall prohibit you from voting securities that you
own in any manner or granting a proxy to another person in respect thereof. 
 Notwithstanding the foregoing, nothing in this letter agreement shall prohibit
you or your affiliates from participating in any “solicitation” of “proxies” (as such terms are used in the proxy rules of the Securities and Exchange Commission) or consents to vote or otherwise with respect to any voting
securities of the Company or any of its subsidiaries in connection with the Company’s 2007 annual meeting (including, without limitation, nominating a slate of directors for election at such annual meeting). For the avoidance of doubt, you
shall not directly or indirectly discuss with or offer to any person (including, without limitation, any affiliate or current joint venture or other partner of or investor in the Company) any position (debt, equity, joint venture or otherwise,
including, without limitation, any continuation or modification of any current arrangement with any such third party) in any possible transaction with the Company or any other form of direct or indirect participation in any possible transaction with
the Company by you and such person without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed (provided, that the Company shall notify you of its consent or refusal no later than 3 business
days following the Company’s receipt of your written request for such consent, and in the absence of such notification the Company shall be deemed to have consented) with respect to any person that has not previously signed a confidentiality
agreement with the Company. 
 Acknowledgement - You acknowledge that the Confidential Information may include material non-public information
concerning the Company and that, under applicable securities laws, including the securities laws of the United States, your receipt of the Confidential Information may restrict your ability to trade in securities of the Company while in possession
of such information. You acknowledge and agree that you are aware of such laws, and that compliance with such laws in your trading activities is your responsibility. 
 Notwithstanding the foregoing, it is understood that you will not wish to be restricted in your ability to trade in securities of the Company for an indefinite period of time. In furtherance of your desire to cleanse
yourself of possessing any potential material non-public information concerning the Company, you may at any time advise the Company that you are delivering to the Company or destroying all Confidential Information and any other material containing
or reflecting any information in the Confidential Information (whether prepared by the Company, its Representatives or otherwise and regardless of the form or storage medium) furnished to you or your Representatives and are not retaining any copies,
extracts or other reproductions in whole or in part of such material (except as may be required to be retained by applicable law, regulation or internal document retention policies, with any such copies to be retained subject to the confidentiality
obligations hereunder), and that you do not wish to receive any other Confidential Information or continue your dialogue with the Company as to Confidential Information. The 

 
Company agrees to honor such request, and not to provide you with any additional Confidential Information, whether in writing, orally or otherwise, after
receiving such request, provided that the return or destruction of such Confidential Information shall not in any event be understood as constituting advice or a representation by the Company that you are no longer in possession of material
non-public information concerning the Company, and any decision as to your future market activities in the securities of the Company shall be solely yours. 
 If, after June 30, 2007 and prior to October 27, 2008, the Company and you are no longer in discussions with respect to a strategic transaction involving you and the Company or its assets, and you reasonably believe that you are
in possession of Confidential Information that constitutes material, non-public information under the U.S. federal securities laws, then you may notify the Company as to which Confidential Information constitutes such material, non-public
information (the “Subject Information”). The Company shall either publicly disclose the Subject Information or permit you to publicly disclose the Subject Information; provided, however, that, if the Company determines that the Subject
Information is not material, non-public information under the U.S. federal securities laws, the Company has the right not to disclose or permit you to disclose the Subject Information so long as it certifies to you in writing that it reasonably
believes that the Subject Information is not material, non-public information under U.S. federal securities laws. 
 Remedies - You understand
and agree that money damages would not be a sufficient remedy for any breach of this letter agreement by you or any of your Representatives and that the Company shall be entitled to equitable relief, including an injunction and specific performance,
as a remedy for such breach. Such remedies shall not be deemed to be the exclusive remedies for a breach by you or any of your Representatives of this letter agreement but shall be in addition to all other remedies available to the Company at law or
in equity. 
 No Representation - You understand that neither the Company nor any of its Representatives have made or make any representation
or warranty as to the accuracy or completeness of the Confidential Information. You agree that neither the Company nor any of its Representatives shall have any liability to you or any of your Representatives resulting from the receipt or use of the
Confidential Information except as may otherwise be expressly provided in a definitive agreement. Neither this letter agreement nor disclosure of any Confidential Information to you shall be deemed by implication or otherwise to vest in you rights
in or to the Confidential Information except as set forth in this letter agreement. 
 No Obligation - The parties agree that unless and until
a definitive agreement between the Company and you with respect to a transaction has been executed and delivered, neither the Company nor you will be under any legal obligation of any kind whatsoever with respect to such a transaction by virtue of
this or any written or oral expression with respect to such a transaction by any of its Representatives except, in the case of this letter agreement, for the matters specifically agreed to herein. For purposes of this letter agreement, the term
“definitive agreement” does not include an executed letter of intent or any other preliminary written agreement, nor does it include any written or oral acceptance of any offer or bid by you. You acknowledge that the Company and its
Representatives shall be free to take such actions regarding any possible transaction and for the dissemination of Confidential Information which 

 
they in their sole discretion shall determine including, without limitation, negotiating with any other party and entering into a definitive transaction
agreement with any other party without prior notice to you or any other person or discontinuing discussions or negotiations with you or any other party at any time for any reason or for no reason. 
 Required Disclosure - In the event that you or any of your Representatives are required or become legally compelled by applicable law, regulation, stock
exchange rule, subpoena, court order or similar process, or are required or requested by governmental, judicial or regulatory authorities having appropriate jurisdiction to disclose any of the Confidential Information, you will, if legally
permitted, promptly provide us with written notice so that we may seek, at our expense, a protective order or other appropriate remedy and/or waive compliance with the provisions of this letter agreement, and you agree to cooperate with us on an
“all reasonable efforts” basis, at our sole cost and expense to obtain such a protective order or other remedy. In the event that such protective order or other remedy is not obtained or we waive compliance with the provisions of this
agreement, you will furnish only that portion of the Confidential Information which you are advised by counsel in writing is required to be disclosed, and you will exercise all reasonable efforts to obtain reasonable assurance that confidential
treatment will be accorded the Confidential Information so furnished. 
 Term - This letter agreement and all of the parties’ obligations
hereunder shall terminate on the date which is two years from the date hereof; provided, however, that liability for any breach of this letter agreement prior to such termination shall survive such termination. 
 Amendment, Non-Waiver, Remedies, Severability, Assignment, Misc. - The agreement set forth in this letter agreement may be modified or waived only by a
separate writing signed by both the Company and you expressly so modifying or waiving such agreement. You agree that no failure or delay by the Company in exercising any right, remedy, power or privilege hereunder will operate as a waiver thereof,
nor will any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege hereunder. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive
of any rights, remedies, powers and privileges provided by law. If any provision of this letter agreement is found to violate any statute, regulation, rule, order or decree of any governmental authority, court, agency or exchange, such invalidity
shall not be deemed to affect any other provision hereof or the validity of the remainder of this letter agreement, and such invalid provision shall be deemed deleted herefrom to the minimum extent necessary to cure such violation. Neither this
letter agreement nor any of the rights and/or obligations hereunder may be assigned, by operation of law or otherwise, by either party without the prior written consent of the other party, except that the Company may assign this letter agreement to
any successor to The Mills Corporation (by merger or otherwise) or to any person that acquires at least a majority of the assets or equity securities of the Company. Any attempted assignment or transfer by either party not in accordance herewith
shall be null and void. This letter agreement is for the benefit of each party and its respective Representatives and their respective successors and permitted assigns. 
 Entire Agreement - This letter agreement and the Stipulated Final Order dated December ____, 2006 (C.A. No. 2530-N, Delaware Court Of Chancery, New Castle County) contain the entire 

 
agreement and supersede all prior agreements and understandings, both written and oral, between the parties with respect to the subject matter hereof and
thereof. 
 Governing Law - This letter agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware.
You hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the courts of the State of Delaware for any actions, suits or proceedings arising out of or relating to this letter agreement (and you agree not to
commence any action, suit or proceeding relating thereto except in such courts, and further agree that service of any process, summons, notice or document by U.S. registered mail to your address set forth above shall be effective service of process
for any action, suit or proceeding brought against you in any such court). You hereby irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or proceeding arising out of this letter agreement in the courts of
the State of Delaware, and hereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.

 (signature page follows) 

 Please confirm your agreement with the foregoing by signing and returning one copy of this letter agreement to the
undersigned, whereupon this agreement shall become a binding agreement between you and the Company. 
  

					
	Very truly yours,
	
	THE MILLS CORPORATION
		
	By:	 	/s/ Mark S. Ordan
		 	Name:	 	Mark S. Ordan
		 	Title:	 	Chief Executive Officer and President

  

					
	Confirmed and Agreed to:
	
	GAZIT-GLOBE LTD.
		
	By:	 	/s/ Chaim Katzman
		 	Name:	 	Chaim Katzman
		 	Title:	 	Chairman

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]